Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recombinant Activated Factor VII (rFVIIa/ NovoSeven®) in the Management of Massive Bleeding in Hospital Universiti Sains Malaysia

NCT03251547 is registered in ClinicalTrials.gov with Universiti Sains Malaysia as lead sponsor.

NCT NCT03251547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03251547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Recombinant Activated Factor VII (rFVIIa/ NovoSeven®) in the Management of Massive Bleeding in Hospital Universiti Sains Malaysia
Lead sponsor
Universiti Sains Malaysia
Phase
Observational
Overall status
Completed
Start date
August 21, 2017
Completion date
November 15, 2017
Enrollment
76 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

massive blood loss, massive blood transfusion; thrombocytopenia, massive hemorrhage